Eurand N.V.: Eurand to Present at Barclays Capital Global Healthcare Conference

Show Health and Fitness Publications

Tue, March 31, 2009

[ Tue, Mar 31st 2009 ] - Market Wire

Targeted Genetics: Targeted Genetics Corporation .. ourth Quarter and Year-End 2008 Financial Results

[ Tue, Mar 31st 2009 ] - Market Wire

Symbollon Pharmaceuticals, Inc.: Symbollon Pharmaceuticals Announces 2008 Year-End Results

[ Tue, Mar 31st 2009 ] - Market Wire

Facet Biotech: Facet Biotech Receives Director Nomination Notice

[ Tue, Mar 31st 2009 ] - Market Wire

Stem Cell Therapy International, Inc.: Stem Cell .. Soon to Be "AmStem") Ready to Replicate

[ Tue, Mar 31st 2009 ] - Market Wire

AVI BioPharma, Inc.: AVI BioPharma Appoints Drs. .. and M. Kathleen Behrens to Its Board of Directors

[ Tue, Mar 31st 2009 ] - Market Wire

SciClone Pharmaceuticals: SciClone and Sigma Tau .. rector Election Contest for 2009 Annual Meeting o

[ Tue, Mar 31st 2009 ] - Market Wire

Skyepharma PLC: Skyepharma - Re Agreement

Mon, March 30, 2009

[ Mon, Mar 30th 2009 ] - Market Wire

FORTIS: Fortis: Results full year 2008

[ Mon, Mar 30th 2009 ] - Market Wire

Forbes Medi-Tech Inc.: CORRECTION FROM SOURCE: Fo .. ncial Results for the Year ended December 31, 200

[ Mon, Mar 30th 2009 ] - Market Wire

MedaSorb Technologies Corporation: CytoSorbents, .. pany Most Likely to Succeed" at the 2009 New

[ Mon, Mar 30th 2009 ] - Market Wire

Atlantis Systems Corp.: Atlantis Systems Corporat .. Announces Resignation From its Board of Directors

[ Mon, Mar 30th 2009 ] - Market Wire

Corcept Therapeutics: Corcept Therapeutics Announ .. ear 2008 Results and Update on Development Progra

[ Mon, Mar 30th 2009 ] - Market Wire

Adherex Technologies Inc.: Adherex Reports 2008 Fiscal Results

[ Mon, Mar 30th 2009 ] - Market Wire

Cytokinetics, Inc.: Cytokinetics Announces Final .. ta for CK-1827452 Presented at the 2009 Annual Sc

[ Mon, Mar 30th 2009 ] - Market Wire

Cypress Bioscience, Inc.: Cypress Bioscience, Inc. to Present at Citi's 4th Annual Biotech Day

Fri, March 27, 2009

[ Fri, Mar 27th 2009 ] - Market Wire

FORTIS: Fortis reaction on decisions of former subsidiairies not to call hybrid instruments

[ Fri, Mar 27th 2009 ] - Market Wire

Gamma Pharmaceuticals Inc.: Gamma Pharmaceuticals .. as Distributor Worth $1,500,000 Retail Market Val

Thu, March 26, 2009

[ Thu, Mar 26th 2009 ] - Market Wire

PDL BioPharma: PDL BioPharma Provides First Quart .. 009 Revenue Guidance of Approximately $60 Million

[ Thu, Mar 26th 2009 ] - Market Wire

HearUSA: HearUSA Reports Fourth Quarter and Fiscal 2008 Results

[ Thu, Mar 26th 2009 ] - Market Wire

DIANOR RESOURCES INC.: Dianor Resources Inc.: Leadbetter Bulk Sampling Plans Filed With MNDM

[ Thu, Mar 26th 2009 ] - Market Wire

AMI Research: AMI Research Updates Q4 Stock Report of NeoGenomics, Inc.

[ Thu, Mar 26th 2009 ] - Market Wire

The Medicines Company: The Medicines Company EU F .. viprex(R) for the Treatment of Acute Hypertension

[ Thu, Mar 26th 2009 ] - Market Wire

Targeted Genetics Corporation: Targeted Genetics .. Webcast Discussion of Fourth Quarter and Year-End

[ Thu, Mar 26th 2009 ] - Market Wire

BIOLASE Technology, Inc.: BIOLASE and NLT Announce Settlement Agreement

[ Thu, Mar 26th 2009 ] - Market Wire

BIOLASE Technology, Inc.: BIOLASE Receives Deficiency Letter From NASDAQ

Wed, March 25, 2009

[ Wed, Mar 25th 2009 ] - Market Wire

Molecular Insight Pharmaceuticals, Inc. : Molecul .. Detailed Phase 2 Trial Results Demonstrating Abi

[ Wed, Mar 25th 2009 ] - Market Wire

Vyteris, Inc.: Vyteris Announces Agreement for Additional Funding

Tue, March 24, 2009

[ Tue, Mar 24th 2009 ] - Market Wire

Myriad Genetics: Myriad Applauds New ACOG Guidelines for Hereditary Breast and Ovarian Cancer

[ Tue, Mar 24th 2009 ] - Market Wire

Cavit Sciences, Inc.: Cavit Sciences in Negotiati .. re Web Portal Company for Healthy Living/Wellness

Mon, March 23, 2009

[ Mon, Mar 23rd 2009 ] - Market Wire

Cytokinetics, Inc.: Cytokinetics Announces Clinic .. -1827452 to be Presented at the 2009 Annual Scien

[ Mon, Mar 23rd 2009 ] - Market Wire

Novogen, Limited: Board Changes at Novogen Limited Announced

[ Mon, Mar 23rd 2009 ] - Market Wire

City Capital Corp.: Despite Economic Downturn, City Capital Corporation Expands Operations

[ Mon, Mar 23rd 2009 ] - Market Wire

Vicor Technologies, Inc.: Vicor Technologies Reta .. ameron Associates for Investor Relations Services

[ Mon, Mar 23rd 2009 ] - Market Wire

HearUSA: HearUSA Sets Fourth Quarter and Year End .. ference Call for Thursday, March 26 at 4:30 PM ET

[ Mon, Mar 23rd 2009 ] - Market Wire

Stem Cell Therapy International, Inc.: Stem Cell .. nnounces Joint Meetings With Global Stem Cell Rep

[ Mon, Mar 23rd 2009 ] - Market Wire

Allana Resources Inc.: Analyst Coverage Initiated on Allana Resources

[ Mon, Mar 23rd 2009 ] - Market Wire

Skyepharma PLC: Skyepharma PLC Announces Regulatory Application

Fri, March 20, 2009

[ Fri, Mar 20th 2009 ] - Market Wire

MDRNA, Inc.: MDRNA, Inc. to Hold Year-End 2008 Ea .. uesday, March 24, 2009, at 8:30 a.m. Eastern Time

[ Fri, Mar 20th 2009 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: William T. McKee Joins Board of Auxilium Pharmaceuticals, Inc.

Thu, March 19, 2009

[ Thu, Mar 19th 2009 ] - Market Wire

Big Stick Media Corporation: Big Stick Media Corp .. inancial Results for Year-Ended November 30, 2008

[ Thu, Mar 19th 2009 ] - Market Wire

BioElectronics Corporation: BioElectronics to Pre .. ip and Health Tech Investment Forum on March 24th

[ Thu, Mar 19th 2009 ] - Market Wire

Meridian Co., Ltd.: Meridian Expands in the Scandinavian Market

[ Thu, Mar 19th 2009 ] - Market Wire

Midland Exploration Inc.: Midland Acquires New Gold Property Along the Destor-Porcupine Fault

[ Thu, Mar 19th 2009 ] - Market Wire

Chembio Diagnostics, Inc.: Chembio Reports 2008 Results

[ Thu, Mar 19th 2009 ] - Market Wire

Syneron Medical Ltd.: Syneron Dental Announces European OEM Agreement

[ Thu, Mar 19th 2009 ] - Market Wire

PDL BioPharma: PDL BioPharma Announces Conversion .. % Convertible Subordinated Notes Due August 16, 2

[ Thu, Mar 19th 2009 ] - Market Wire

Clariant AG: Clariant Appoints Mathias Lütgendorf Member of the Executive Committee

Wed, March 18, 2009

[ Wed, Mar 18th 2009 ] - Market Wire

CV Therapeutics, Inc.: CV Therapeutics' Board of .. ders Accept Gilead Sciences' $20.00 per Share Cas

[ Wed, Mar 18th 2009 ] - Market Wire

Marani Brands, Inc.: Marani Vodka Spirit Awarded .. 9 by The American Academy of Hospitality Sciences

[ Wed, Mar 18th 2009 ] - Market Wire

Marshall Edwards, Inc.: Triphendiol Safety Data C .. Be Studied Further in the Treatment of Pancreati

[ Wed, Mar 18th 2009 ] - Market Wire

Vicor Technologies, Inc.: Vicor Technologies Begi .. Study Under Research Agreement With University o

[ Wed, Mar 18th 2009 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. icals to Present at Citi's 4th Annual Biotech Day

[ Wed, Mar 18th 2009 ] - Market Wire

Cypress Bioscience, Inc.: Cypress Bioscience, Inc .. en and Company 29th Annual Health Care Conference

Tue, March 17, 2009

[ Tue, Mar 17th 2009 ] - Market Wire

Stem Cell Therapy International, Inc.: Stem Cell .. national Inc. Announces Bridge Financing Obtained

[ Tue, Mar 17th 2009 ] - Market Wire

IDO Security, Inc.: IDO Security Announces Delivery of MagShoe to Multiple Clients

[ Tue, Mar 17th 2009 ] - Market Wire

Nanobac Pharmaceuticals: Nanobac Pharmaceuticals and Eureka Genomics Agree to Terms for Merger

[ Tue, Mar 17th 2009 ] - Market Wire

Edwards Lifesciences: Edwards Lifesciences Comple .. l Study Arm of U.S. Clinical Trial for Transcathe

[ Tue, Mar 17th 2009 ] - Market Wire

BioElectronics Corporation: BioElectronics Announces Menstrual Pain Clinical Study

[ Tue, Mar 17th 2009 ] - Market Wire

Chembio Diagnostics, Inc.: Chembio to Host Conference Call to Discuss 2008 Financial Results

[ Tue, Mar 17th 2009 ] - Market Wire

Eurand N.V.: Eurand Announces International Agree .. s for Once-Daily Extended Release Muscle Relaxant

Mon, March 16, 2009

[ Mon, Mar 16th 2009 ] - Market Wire

BIOLASE Technology, Inc.: BIOLASE Reports Fourth Quarter, Year-End Results

[ Mon, Mar 16th 2009 ] - Market Wire

Facet Biotech: Facet Biotech Provides 2009 Financial Guidance and Lowers Cash Utilization Estimate

[ Mon, Mar 16th 2009 ] - Market Wire

CV Therapeutics, Inc.: CV Therapeutics Announces .. College of Cardiology 58th Annual Scientific Ses

[ Mon, Mar 16th 2009 ] - Market Wire

Lakeland Industries, Inc.: EdgeWater Research Inv .. Highlights Lakeland Industries as Featured Stock

[ Mon, Mar 16th 2009 ] - Market Wire

Molecular Insight Pharmaceuticals, Inc. : Molecul .. nc. Announces Fourth Quarter and Year-End 2008 Fi

[ Mon, Mar 16th 2009 ] - Market Wire

Cypress Bioscience: Cypress Bioscience, Inc. Announces 2008 Financial Results

Sun, March 15, 2009

[ Sun, Mar 15th 2009 ] - Market Wire

Diagnostic Imaging International Corp.: Diagnosti .. ernational Corp.-Closes Acquisition and Financing

[ Sun, Mar 15th 2009 ] - Market Wire

FORTIS: Fortis holding pays no dividend for the 2008 financial year

[ Sun, Mar 15th 2009 ] - Market Wire

FORTIS: Memorandum of Understanding Between Fortis and Ping An Expired

Fri, March 13, 2009

[ Fri, Mar 13th 2009 ] - Market Wire

Midland Exploration Inc.: Midland Exploration Inc.: Amendment to Stock Option Plan

[ Fri, Mar 13th 2009 ] - Market Wire

Bennett Environmental Inc.: Bennett Environmental .. Reports Fourth Quarter and 2008 Year End Results

[ Fri, Mar 13th 2009 ] - Market Wire

SCOR: Standard & Poor's upgrades SCOR to "A"

[ Fri, Mar 13th 2009 ] - Market Wire

Molecular Insight Pharmaceuticals, Inc. : Molecul .. nc. to Announce Fourth Quarter, Year-End 2008 Fin

[ Fri, Mar 13th 2009 ] - Market Wire

San Anton Resource Corporation: San Anton Announces Kings Minerals Share Purchase Plan Offer

[ Fri, Mar 13th 2009 ] - Market Wire

Lpath, Inc.: Lpath to Hire Clinical Head

[ Fri, Mar 13th 2009 ] - Market Wire

MoneyTV; Hydrogen Hybrid Corporation; AlphaTrade. .. ; Cord Blood America, Inc.: MoneyTV, Week of 3/13

Thu, March 12, 2009

[ Thu, Mar 12th 2009 ] - Market Wire

Pacific Energy Resources Ltd.: Court Enters Order .. Trading in Stock of Pacific Energy Resources Ltd.

[ Thu, Mar 12th 2009 ] - Market Wire

AspenBio Pharma, Inc.: AspenBio Pharma to Proceed With FDA 510(k) Application for AppyScore(TM)

[ Thu, Mar 12th 2009 ] - Market Wire

Harte Gold Corp.: Harte Gold Corp. Corporate Update

[ Thu, Mar 12th 2009 ] - Market Wire

Sanguine Corporation: Sanguine Corp Announces Let .. mmitment to License PHER-O2 to Rockland Technimed

[ Thu, Mar 12th 2009 ] - Market Wire

Pacific Energy Resources Ltd.: TSX Suspends Trading; Subsequent Delisting

[ Thu, Mar 12th 2009 ] - Market Wire

AspenBio Pharma, Inc.: AspenBio Pharma to Host Investor Update Call Today at 4:30 PM ET

[ Thu, Mar 12th 2009 ] - Market Wire

Urigen Pharmaceuticals: Urigen Pharmaceuticals, I .. rey G. Proctor, M.D. to Scientific Advisory Board

[ Thu, Mar 12th 2009 ] - Market Wire

Electro-Optical Sciences, Inc.: Electro-Optical S .. Data From MelaFind(R) Pivotal Study Presented at

Wed, March 11, 2009

[ Wed, Mar 11th 2009 ] - Market Wire

Molecular Insight Pharmaceuticals, Inc. : Molecul .. Protocol Assessment Approval From FDA for Phase 2

[ Wed, Mar 11th 2009 ] - Market Wire

PDL BioPharma: PDL BioPharma Elects Frederick Frank and Jody Lindell to Its Board of Directors

[ Wed, Mar 11th 2009 ] - Market Wire

DUSA Pharmaceuticals, Inc.: DUSA Pharmaceuticals .. ll Year 2008 Corporate Highlights and Financial R

Tue, March 10, 2009

[ Tue, Mar 10th 2009 ] - Market Wire

Watson Pharmaceuticals: Watson to Present at Cowen and Company 29th Annual Health Care Conference

[ Tue, Mar 10th 2009 ] - Market Wire

Trinity Biotech: Trinity Biotech Announces Quarter 4 Results

[ Tue, Mar 10th 2009 ] - Market Wire

Allana Resources Inc.: Allana Resources Appoints .. a Biya Senior Vice President Business Development

[ Tue, Mar 10th 2009 ] - Market Wire

AVI BioPharma, Inc.: AVI BioPharma Announces Fourth Quarter and Year End 2008 Financial Results

[ Tue, Mar 10th 2009 ] - Market Wire

Vyteris, Inc.: Vyteris Initiates Phase II Clinica .. nfertility Treatment Using Smart Patch Technology

[ Tue, Mar 10th 2009 ] - Market Wire

Eurand N.V.: FDA Grants Orphan Drug Designation for EUR-1073

[ Tue, Mar 10th 2009 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. en and Company 29th Annual Health Care Conference

Mon, March 9, 2009

[ Mon, Mar 09th 2009 ] - Market Wire

Trinity Biotech: Trinity Biotech Announces Commencement of TRI-stat(TM) CLIA Trials

[ Mon, Mar 09th 2009 ] - Market Wire

PDL BioPharma: PDL BioPharma to Present at the Co .. h Annual Health Care Conference on March 18, 2009

[ Mon, Mar 09th 2009 ] - Market Wire

Dragon Pharmaceutical Inc.: Dragon Pharmaceutical .. Pharmaceutical Client Increases Clavulanic Acid O

[ Mon, Mar 09th 2009 ] - Market Wire

XELR8 Holdings, Inc.: XELR8 Holdings Begins Trading Under New Symbol XELR

[ Mon, Mar 09th 2009 ] - Market Wire

Wellstar International, Inc.: Wellstar International, Inc. Secures $250,000 of New Financing

[ Mon, Mar 09th 2009 ] - Market Wire

Human Genome Sciences, Inc.: Human Genome Science .. in Second of Two Phase 3 Trials of Albuferon(R) i

[ Mon, Mar 09th 2009 ] - Market Wire

SciClone Pharmaceuticals, Inc.: SciClone Complete .. e in Phase 2 Trial for RP101 in Late-Stage Pancre

[ Mon, Mar 09th 2009 ] - Market Wire

Cypress Bioscience, Inc.: Cypress Bioscience, Inc .. at Barclays Capital Global Healthcare Conference

Fri, March 6, 2009

[ Fri, Mar 06th 2009 ] - Market Wire

SCOR: SCOR announces the publication of its 2008 Registration Document

[ Fri, Mar 06th 2009 ] - Market Wire

Bennett Environmental Inc.: Bennett Environmental Inc. Announces Appeal Result

[ Fri, Mar 06th 2009 ] - Market Wire

MediSys Corporation: MediSys Corporation Launches New Web Site

[ Fri, Mar 06th 2009 ] - Market Wire

DUSA Pharmaceuticals, Inc.: DUSA Pharmaceuticals, .. er and Full Year 2008 Financial Results and Corpo

[ Fri, Mar 06th 2009 ] - Market Wire

MDRNA, Inc.: MDRNA, Inc. Receives Delisting Notice From NASDAQ and Requests Hearing

[ Fri, Mar 06th 2009 ] - Market Wire

Trinity Biotech: Trinity Biotech plc to Announce .. uarter and Fiscal 2008 Year-End Financial Results

[ Fri, Mar 06th 2009 ] - Market Wire

Skyepharma PLC: Skyepharma PLC announces Conversion of Bonds

[ Fri, Mar 06th 2009 ] - Market Wire

Asher Xino Corporation: AsherXino Corporation Appoints Jack Webb Vice Chairman

Thu, March 5, 2009

[ Thu, Mar 05th 2009 ] - Market Wire

BIOLASE Technology, Inc.: BIOLASE Announces Appointment of David Mulder to CEO

[ Thu, Mar 05th 2009 ] - Market Wire

Cord Blood America: Cord Blood America Top Stock .. Global Stem Cell and Regenerative Medicine Index

[ Thu, Mar 05th 2009 ] - Market Wire

Skyepharma PLC: Skyepharma PLC announces Consultation Process

[ Thu, Mar 05th 2009 ] - Market Wire

CV Therapeutics, Inc.: CV Therapeutics Reports Ph .. Concept for CVT-3619, a Novel Potential Treatment

[ Thu, Mar 05th 2009 ] - Market Wire

Eurand N.V.: Eurand Reports Recent Developments a .. urth Quarter and Full-Year 2008 Financial Results

Wed, March 4, 2009

[ Wed, Mar 04th 2009 ] - Market Wire

Wellstar International, Inc.: Wellstar Internatio .. l, Inc. Signs LOI for up to $1 Million in Funding

[ Wed, Mar 04th 2009 ] - Market Wire

Constellation Software Inc.: Constellation Softwa .. the Fourth Quarter and Year Ended December 31, 2

[ Wed, Mar 04th 2009 ] - Market Wire

Trinity Biotech: Trinity Biotech Announces Its Fi .. st 3 Destiny Max Placements in the United Kingdom

[ Wed, Mar 04th 2009 ] - Market Wire

Eurand N.V.: Eurand to Present at Cowen Health Care Conference

[ Wed, Mar 04th 2009 ] - Market Wire

Syneron Medical Ltd.: Syneron(TM) Unveils New eMa .. ctional Treatments for Darker Skin Types at Ameri

[ Wed, Mar 04th 2009 ] - Market Wire

AVI BioPharma, Inc.: AVI BioPharma Announces Four .. d Year End 2008 Financial Results Conference Call

Tue, March 3, 2009

[ Tue, Mar 03rd 2009 ] - Market Wire

SCOR: SCOR records solid results with a net incom .. ed by an outstanding liquidity position of EUR 3.

[ Tue, Mar 03rd 2009 ] - Market Wire

XELR8 Holdings, Inc.: XELR8 Holdings Loses Appeal at the NYSE Alternext

[ Tue, Mar 03rd 2009 ] - Market Wire

Myriad Genetics: Myriad Genetics to Present at Cowen Health Care Conference on March 17, 2009

[ Tue, Mar 03rd 2009 ] - Market Wire

Anaconda Mining Inc.: Anaconda Announces Initiati .. of Arbitration Process With JV Partner New Island

[ Tue, Mar 03rd 2009 ] - Market Wire

Given Imaging: Given Imaging Sets Dividend Distribution Date

[ Tue, Mar 03rd 2009 ] - Market Wire

X PRIZE Foundation: X PRIZE Foundation, WellPoint .. Hold Advisory Summit to Propose Ideas for Health

[ Tue, Mar 03rd 2009 ] - Market Wire

FONAR Corporation: FONAR Enters Africa and Middle .. kets With Sale to Leading Medical Center in Libya

[ Tue, Mar 03rd 2009 ] - Market Wire

SciClone Pharmaceuticals, Inc.: SciClone Reports .. Results for the Fourth Quarter and Year-End 2008

Mon, March 2, 2009

[ Mon, Mar 02nd 2009 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Submits .. for XIAFLEX(TM) for the Treatment of Dupuytren's

[ Mon, Mar 02nd 2009 ] - Market Wire

Wellstar International, Inc.: Wellstar/TMI to Uti .. Board Members in the Marketing of Imaging Systems

[ Mon, Mar 02nd 2009 ] - Market Wire

PDL BioPharma: PDL BioPharma Announces Fourth Quarter and Full Year 2008 Financial Results

[ Mon, Mar 02nd 2009 ] - Market Wire

NeuroInvestment: Migraine Therapeutics Reviewed by NeuroInvestment

[ Mon, Mar 02nd 2009 ] - Market Wire

Hansen Medical, Inc.: Hansen Medical Announces St .. anced Cardiac Therapeutics and Procurement of Cer

[ Mon, Mar 02nd 2009 ] - Market Wire

Watson Pharmaceuticals: Watson to Present at Barclays Capital Global Healthcare Conference

[ Mon, Mar 02nd 2009 ] - Market Wire

Pentaho Corporation: Cardiac Science Selects Pentaho to Streamline Information Integration

[ Mon, Mar 02nd 2009 ] - Market Wire

Targeted Genetics: Targeted Genetics Provides Business Update and Announces Extended Cash Horizon

Fri, February 27, 2009

[ Fri, Feb 27th 2009 ] - Market Wire

Nanobac Pharmaceuticals: Nanobac Message to Shareholders

[ Fri, Feb 27th 2009 ] - Market Wire

Health Net Federal Services Wins Department of Ve .. d Outpatient Clinic Contract in Durango, Colorado

[ Fri, Feb 27th 2009 ] - Market Wire

CONMED Corporation: CONMED Corporation Sets Annual Meeting Date

[ Fri, Feb 27th 2009 ] - Market Wire

AMAG Pharmaceuticals, Inc. Reports Financial Resu .. for the Quarter and Year Ended December 31, 2008

[ Fri, Feb 27th 2009 ] - Market Wire

BIOLASE Technology, Inc.: BIOLASE Launches New Wa .. se(R) MD Turbo(TM) All-Tissue Dental Laser System

[ Fri, Feb 27th 2009 ] - Market Wire

EPIX Pharmaceuticals Announces Resignation of Chief Business Officer

[ Fri, Feb 27th 2009 ] - Market Wire

Panacos Announces Voluntary Decision to Delist Co .. aq and Terminate SEC Registration of Common Stock

[ Fri, Feb 27th 2009 ] - Market Wire

Alexion Joins NORD and EURORDIS in Supporting the Goals of Rare Disease Day

Thu, February 26, 2009

[ Thu, Feb 26th 2009 ] - Market Wire

European Authorities Approve Larger-Scale Production of Genzyme?s Myozyme

[ Thu, Feb 26th 2009 ] - Market Wire

A Senior Cancer Researcher Joins PhytoMedical on .. uccessful Preclinical Study on Human Brain Cancer

[ Thu, Feb 26th 2009 ] - Market Wire

ArQule to Report Fiscal 2008 Financial Results on March 5, 2009

[ Thu, Feb 26th 2009 ] - Market Wire

70 Abstracts Evaluatingthe Potential of Celgene P .. Be Presented at the 12th International Myeloma W

[ Thu, Feb 26th 2009 ] - Market Wire

Conceptus Appoints John L. Bishop to Board of Directors

[ Thu, Feb 26th 2009 ] - Market Wire

Natus Medical Announces Record 2008 Fourth Quarter and Full Year Results

[ Thu, Feb 26th 2009 ] - Market Wire

Regeneron Reports Full Year and Fourth Quarter 2008 Financial and Operating Results

[ Thu, Feb 26th 2009 ] - Market Wire

Zacks Bull & Bear of the Day Highlights: Pozen In .. Corp., Agrium, CF Industries and Terra Industries

Wed, February 25, 2009

[ Wed, Feb 25th 2009 ] - Market Wire

Data on PolyMedix Antimicrobial Compounds Present .. robiology 7th Annual Biodefense and Emerging Dise

[ Wed, Feb 25th 2009 ] - Market Wire

Anika Therapeutics Announces Date of Fourth Quart .. d Year End 2008 Financial Results Conference Call

[ Wed, Feb 25th 2009 ] - Market Wire

Dyax Corp. Announces Fourth Quarter and Year End 2008 Financial Results

[ Wed, Feb 25th 2009 ] - Market Wire

Adipose-Derived Stem and Regenerative Cells Preve .. ity and Reduce Kidney Damage in Preclinical Study

[ Wed, Feb 25th 2009 ] - Market Wire

Ceragenix and Pediapharm Enter Into Distribution and Supply Agreement for EpiCeram®

[ Wed, Feb 25th 2009 ] - Market Wire

A.P. Pharma Appoints John B. Whelan as Chief Financial Officer

[ Wed, Feb 25th 2009 ] - Market Wire

Zacks Industry Outlook Highlights: Immucor

[ Wed, Feb 25th 2009 ] - Market Wire

Elan Announces Further Alignment of Resources as Part of On-Going Strategic Review Process

Tue, February 24, 2009

[ Tue, Feb 24th 2009 ] - Market Wire

HemaCare Corporation: HemaCare Reports Record 4th Quarter and 2008 Revenues

[ Tue, Feb 24th 2009 ] - Market Wire

Free Electronic Prescribing Service Now Available to San Antonio Physicians

[ Tue, Feb 24th 2009 ] - Market Wire

Assisted Living Concepts, Inc.: Assisted Living C .. Fourth Quarter and Full Year Results -- Solid Fou

[ Tue, Feb 24th 2009 ] - Market Wire

St. Jude Medical Receives Australian TGA Regulato .. for the World?s Smallest and Longest-Lasting Rec

[ Tue, Feb 24th 2009 ] - Market Wire

Cypress Bioscience Inc.: Cypress Bioscience, Inc. .. ne Technology Platform From Cellatope Corporation

[ Tue, Feb 24th 2009 ] - Market Wire

CPEX Pharmaceuticals Initiates Phase II Clinical Trial of Nasulin®

[ Tue, Feb 24th 2009 ] - Market Wire

Resumen: Biogen Idec nombra a Michael Lytton vicepresidente ejecutivo de desarrollo empresarial

[ Tue, Feb 24th 2009 ] - Market Wire

Bioject Enters into a Collaborative Research Agre .. IAVI for the Delivery of an HIV Vaccine Candidate

Mon, February 23, 2009

[ Mon, Feb 23rd 2009 ] - Market Wire

Aradigm Announces $4.1 Million Registered Direct Offering

[ Mon, Feb 23rd 2009 ] - Market Wire

Flamel Technologies Announces Appointment of Jeffery S. Vick as Chief Business Officer

[ Mon, Feb 23rd 2009 ] - Market Wire

CytRx?s Arimoclomol to be Administered in a Phase .. l Trial in a Subset of Patients with Familial ALS

[ Mon, Feb 23rd 2009 ] - Market Wire

Celsion to Report Clinical Trial Update of Thermo .. Breast Cancer Study at the Society for Thermal Me

[ Mon, Feb 23rd 2009 ] - Market Wire

GTx Initiates Phase I Clinical Trial for GTx-758, .. ng Hormone Inhibitor for Advanced Prostate Cancer

[ Mon, Feb 23rd 2009 ] - Market Wire

Japanese Researchers Find CSA-13 May Be Useful fo .. reatment of Dental Caries and Periodontal Disease

[ Mon, Feb 23rd 2009 ] - Market Wire

CytoCore Signs Agreement to Sell Synermed?s General Cytology Preservative with SoftPAP

[ Mon, Feb 23rd 2009 ] - Market Wire

Cardima Completes Second Atrial Fibrillation Training Session in Thailand

Sun, February 22, 2009

[ Sun, Feb 22nd 2009 ] - Market Wire

Astellas Pharma Issues Statement Regarding CV Therapeutics Rejection of All-Cash Proposal

Fri, February 20, 2009

[ Fri, Feb 20th 2009 ] - Market Wire

Study of Genzyme Oral Compound for Gaucher Disease Meets Primary Endpoint

[ Fri, Feb 20th 2009 ] - Market Wire

ARIAD Announces $24.3 Million Registered Direct Financing

[ Fri, Feb 20th 2009 ] - Market Wire

Targanta Enters into Memorandum of Understanding to Resolve Shareholder Lawsuit

[ Fri, Feb 20th 2009 ] - Market Wire

EnteroMedics Announces $15.89 Million Private Placement

[ Fri, Feb 20th 2009 ] - Market Wire

StemCells, Inc. Comments on PLoS Medicine Article Concerning Cell Transplants in Russia

[ Fri, Feb 20th 2009 ] - Market Wire

EPIX Pharmaceuticals to Present Preclinical Data for Two Programs at Keystone Symposia

[ Fri, Feb 20th 2009 ] - Market Wire

WellCare Responding to Concerns Raised by Centers for Medicare & Medicaid Services

[ Fri, Feb 20th 2009 ] - Market Wire

Strategic Re-alignment Continues - Fourth Quarter 2008 Financial Results Reported

Thu, February 19, 2009

[ Thu, Feb 19th 2009 ] - Market Wire

Medtronic Board Approves Fourth Quarter Cash Dividend

[ Thu, Feb 19th 2009 ] - Market Wire

XELR8 Holdings, Inc.: XELR8 Holdings, Inc. Retain .. LC to Implement Global Investor Relations Program

[ Thu, Feb 19th 2009 ] - Market Wire

AVI BioPharma, Inc.: AVI BioPharma Announces Trea .. temic Clinical Trial of AVI-4658 for Treatment of

[ Thu, Feb 19th 2009 ] - Market Wire

Seattle Genetics Initiates Pivotal Trial of SGN-35 for Hodgkin Lymphoma

[ Thu, Feb 19th 2009 ] - Market Wire

MiddleBrook Pharmaceuticals Schedules Conference .. 08 Fourth Quarter and Full-Year Financial Results

[ Thu, Feb 19th 2009 ] - Market Wire

Enzon Reports 2008 Results

[ Thu, Feb 19th 2009 ] - Market Wire

Forensic DNA Shown to Lower Crime Rates and Decrease Property Loss

[ Thu, Feb 19th 2009 ] - Market Wire

Antigenics Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights

Wed, February 18, 2009

[ Wed, Feb 18th 2009 ] - Market Wire

Publicatie van landmarkstudie in The Lancet Oncol .. ziene algehele overleving met Vidaza® van Celgen

[ Wed, Feb 18th 2009 ] - Market Wire

Vertex Pharmaceuticals Announces Pricing of Common Stock Offering

[ Wed, Feb 18th 2009 ] - Market Wire

Gilead Receives Response From U.S. FDA on Company .. Resolution for Aztreonam for Inhalation Solution

[ Wed, Feb 18th 2009 ] - Market Wire

Resumen: Estudio revelador publicado en The Lance .. � de Celgene demuestra supervivencia sin preceden

[ Wed, Feb 18th 2009 ] - Market Wire

Remedent, Inc.: Remedent Sets Third Fiscal Quarte .. ce Call for Tuesday, February 24 at 11:00 a.m. ET

[ Wed, Feb 18th 2009 ] - Market Wire

Human BioSystems: Human BioSystems (HBSC) Signs N .. f Intent for a Reverse Merger With San West, Inc.

Eurand N.V.: Eurand to Present at Barclays Capital Global Healthcare Conference

_{//health-fitness.news-articles.net/content/2009/ .. rclays-capital-global-healthcare-conference.html}
^{Published in Health and Fitness on Thursday, February 26th 2009 at 9:20 GMT, Last Modified on 2009-02-26 09:20:49 by Market Wire}

PHILADELPHIA, PA--(Marketwire - February 26, 2009) - Eurand N.V. (NASDAQ: [ EURX ]), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, announced today that it is scheduled to present at the upcoming Barclays Capital Global Healthcare Conference. Gearóid Faherty, Eurand's Chairman and Chief Executive Officer, will be presenting.

 Event: Barclays Capital Global Healthcare Conference Date: Tuesday, March 10, 2009 Time: 2:30 p.m. ET Location: Loews Miami Beach Hotel

An audio webcast of the presentation will be available by accessing the investor relations section of Eurand's web site at [ www.eurand.com ]. A replay of the presentation will be available until March 17, 2009.

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. Eurand has had four products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking orally disintegrating tablet (ODT) formulations, and drug conjugation.

Eurand is a global company with facilities in the U.S. and Europe. For more information, visit Eurand's website at [ www.eurand.com ].

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire

Similar Health and Fitness Publications

[ Thu, Feb 19th 2009 ] - Market Wire

Santarus Reports Preliminary 2008 Total Revenues of $130 Million

[ Mon, Feb 09th 2009 ] - Market Wire

Eurand N.V.: Eurand Announces Conference Call on .. urth Quarter and Full-Year 2008 Financial Results

[ Mon, Feb 09th 2009 ] - Market Wire

SciClone Pharmaceuticals, Inc.: SciClone Issues G .. hrough to Profitability for the Full Year of 2009

[ Wed, Feb 04th 2009 ] - Market Wire

Theravance, Inc.: GSK and Theravance announce pos .. nce-daily fluticasone furoate in the treatment of

[ Thu, Jan 29th 2009 ] - Market Wire

Eurand: Eurand to Present at Deutsche Bank Securities Small- and Mid-Cap Conference

[ Thu, Jan 29th 2009 ] - Market Wire

Eurand N.V.: FDA Accepts Eurand's Response to Approvable Letter for EUR-1008 as Complete

[ Wed, Jan 14th 2009 ] - Market Wire

PPD Issues 2009 Financial Guidance

[ Mon, Jan 12th 2009 ] - Market Wire

Bristol-Myers Squibb and ZymoGenetics Enter Global Collaboration on Novel Hepatitis C Compound

[ Wed, Jan 07th 2009 ] - Market Wire

Facet Biotech: Facet Biotech Announces Restructur .. ng and Provides Estimate of 2009 Cash Utilization

[ Mon, Dec 22nd 2008 ] - Market Wire

Theravance, Inc.: GSK and Theravance Announce Pos .. BA '444 in the Treatment of COPD in the Horizon D

[ Wed, Dec 17th 2008 ] - Market Wire

GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance

[ Tue, Dec 02nd 2008 ] - Market Wire

Theravance, Inc.: GSK and Theravance Announce Pos .. BA, '444 in the Horizon Asthma Development Progra